Intro Pricing vs Ongoing Pricing: The Month One Trap

Month one pricing is where people get hypnotized when searching for a GLP-1 provider.

A lot of providers aren’t lying. They’re anchoring you. They show you the easiest month, the lowest number, the cleanest scenario, and let your brain do the rest.

The cost that matters is steady-state. The price you pay once the promo ends and the program settles into its normal rhythm.

The pricing story vs the pricing reality

There’s the number you see first, and the number you end up budgeting around.

Intro pricing is an acquisition tool. It gets you through the door. Ongoing pricing is the real relationship in how GLP-1 provider costs work.

The “steady-state cost” lens that makes pricing comparable

If you want to compare providers without getting played by marketing math, stop asking “what’s the starting price” and start asking “what’s the steady-state monthly cost.”

Steady-state cost means:

• What you pay after the promo ends.
• What you pay when you’re no longer on the lowest tier.
• What you pay once the billing structure is actually in motion.

Intro pricing can be real and still be misleading.

Micro-scenario: $199 month one, $499 month two:

A user joins at $199. They feel like they found a deal. Month two hits: membership renews and medication is billed separately, or the pricing tier changes. Now it’s $499. They feel tricked. Most of the time the second number wasn’t hidden. It just wasn’t emphasized.

The goal isn’t to shame intro pricing. The goal is to compare apples to apples.

The most common intro pricing patterns

Intro pricing shows up in a few predictable costumes.

Discounted first month

The first month is lower than normal, then the program renews at the standard rate.

This is the cleanest version when it’s disclosed clearly.

“Starting at” tied to the lowest tier or lowest dose

You’ll see “starting at” language because it’s technically true.

It just usually reflects the lowest possible scenario, not what most people pay over time.

If the pricing page doesn’t show what happens after the lowest tier, “starting at” is not a price. It’s an invitation to assume.

First month covers membership only

Some programs charge an initial fee for access and review, and medication is billed later after approval.

That can be legitimate. It becomes a problem when the initial price is presented like it includes everything.

Bundled “first shipment” pricing

Some offers bundle the first shipment into a promo package. That can make month one feel like a deal while ongoing costs are higher.

This is fine when the ongoing cost is obvious. It’s manipulative when the ongoing cost is foggy.

Why ongoing pricing rises for totally normal reasons

The best way to avoid rage is to understand why the number changes even when you didn’t “do anything.”

A lot of price increases aren’t punishment. They’re structure.

The promo window ends

The most common reason.

The discounted month ends and your cost returns to the standard rate.

The billing structure kicks in fully

In split-billing models, month one can be only part of the full cost.

Membership might be charged at signup. Medication might be billed after approval. So month one looks artificially low because the costs arrive in phases.

Pricing changes as dose changes

Many programs price medication differently as dose changes. Some keep a flat rate. Some step up.

If a provider prices by dose, steady-state pricing will often be higher than the lowest-dose teaser.

Fees become visible after signup

• Shipping can be included or separate.
• Add-ons may be optional but commonly selected.
• Labs might be part of certain models.

None of these are automatically bad. They’re only bad when they’re unclear before payment.

Micro-scenario: “I didn’t change anything but the price changed”:

A user renews and sees a higher number. They assume the provider changed prices. In reality, the promo ended, or the medication was billed separately, or the plan moved to standard pricing. The change feels unfair because the user thought month one was the baseline.

Month one is rarely the baseline.

Where people get burned

Most bad pricing experiences are not about the final number. They’re about the surprise.

Here’s where the surprise usually comes from.

Assuming month one equals month twelve

People see a low number and build their budget around it.

Then they feel like the provider “raised prices” when the promo ends.

Not separating membership from medication

If you don’t know whether the headline price includes medication, you’re not comparing pricing. You’re comparing vibes.

This is where split billing wrecks people. It can be legitimate and still create distrust if it isn’t crystal clear.

Missing renewal and cancellation cutoffs

Subscriptions don’t care how annoyed you are. They care what the policy says.

If renewal happens before you cancel, month two hits even if you planned to “try it once.”

Micro-scenario: cancel after the cutoff:

A user assumes they can cancel any time. They attempt to cancel after a renewal window. They get billed. Now the provider looks predatory even if the policy was disclosed. This is why cancellation rules are part of pricing reality.

Comparing two providers using teaser numbers

• Provider A: low month one, higher month two.
• Provider B: higher month one, steady ongoing.

If you compare month one to month one, you make the wrong decision.

How to compute true monthly cost before you pay

You don’t need a finance degree. You just need to force the pricing into the same format.

Ask and answer these five questions:

• What is the recurring membership fee.
• What is the recurring medication cost range.
• Does the cost change as dose changes.
• What renews automatically and when.
• What one-time fees exist, including shipping and labs if applicable.

Then ask the question most pricing pages avoid:

What does month two cost in a normal scenario?

That one question cuts through almost every intro pricing trick.

Micro-example with numbers:

• Provider A: $199 month one, then $399 plus medication that varies.
• Provider B: $449 all-in, stable month to month.

Provider A might still be cheaper long term. Or not. You can’t know until you compute steady-state.

When intro pricing is fine vs when it’s manipulative

Intro pricing can be fair. It can also be a trap.

Intro pricing is fine when

• The standard monthly price is visible.
• The promo terms are obvious.
• You can compute month two without guessing.
• Split billing is disclosed clearly before payment.

Intro pricing is manipulative when

• “Starting at” is the only number you can see.
• Medication cost is hidden until after payment.
• The timing of charges isn’t explained.
• Support can’t answer basic questions directly.

The big signal is this: can you compute what you’ll pay next month before you pay today?

If you can’t, the offer is designed to be hard to compare.

Wrap-up

Intro pricing is the story. Ongoing pricing is the budget.

The only clean way to compare providers is steady-state cost: what you pay after promos end and the structure is actually running. If a provider wants you to focus on month one, it’s usually because month two is less exciting.